SMS Pharmaceuticals Limited (NSE:SMSPHARMA)

SMS Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	20,894	15,089	4,931	7,915	10,518	2,277
Market Cap Growth	101.22%	206.01%	-37.70%	-24.75%	361.90%	-57.10%
Enterprise Value	23,657	17,527	7,463	10,083	12,305	3,643
Last Close Price	235.69	178.06	58.04	92.85	123.15	26.66
PE Ratio	30.14	30.28	-	12.72	16.82	7.21
PS Ratio	2.68	2.13	0.95	1.52	1.87	0.55
PB Ratio	3.71	2.81	1.07	1.68	2.56	0.65
P/TBV Ratio	3.72	2.83	1.07	1.69	2.57	0.66
P/FCF Ratio	-	-	-	44.44	-	-
P/OCF Ratio	-	30.10	21.96	17.57	11.63	5.73
EV/Sales Ratio	3.03	2.47	1.43	1.94	2.19	0.88
EV/EBITDA Ratio	17.81	15.00	13.79	8.83	10.20	4.44
EV/EBIT Ratio	23.23	20.38	32.88	12.14	12.37	5.98
EV/FCF Ratio	-	-	-	56.61	-	-
Debt / Equity Ratio	0.51	0.52	0.55	0.56	0.62	0.45
Debt / EBITDA Ratio	2.19	2.39	4.64	2.29	2.09	1.89
Debt / FCF Ratio	-	-	-	14.78	-	-
Asset Turnover	-	0.74	0.60	0.62	0.79	0.71
Inventory Turnover	-	2.18	1.64	1.70	2.84	2.11
Quick Ratio	-	0.86	0.68	0.58	0.83	0.53
Current Ratio	-	1.61	1.61	1.92	1.58	1.51
Return on Equity (ROE)	-	10.00%	-1.52%	14.13%	16.48%	9.42%
Return on Assets (ROA)	-	5.62%	1.63%	6.21%	8.76%	6.53%
Return on Capital (ROIC)	7.72%	7.02%	1.96%	7.42%	10.62%	7.85%
Return on Capital Employed (ROCE)	-	12.20%	3.60%	12.50%	16.10%	13.20%
Earnings Yield	3.16%	3.30%	-1.43%	7.86%	5.95%	13.87%
FCF Yield	-	-0.14%	-1.52%	2.25%	-5.83%	-1.33%
Dividend Yield	0.17%	0.22%	0.52%	0.32%	0.24%	0.94%
Payout Ratio	-	5.10%	-	4.08%	-	13.41%
Buyback Yield / Dilution	0.31%	-	-	-	-	-
Total Shareholder Return	0.48%	0.22%	0.52%	0.32%	0.24%	0.94%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.